Treatment for Adolescent with Panic Attacks and Social Anxiety Disorder

First-Line Treatment Approach

• The American Academy of Child and Adolescent Psychiatry recommends combination treatment with cognitive-behavioral therapy (CBT) plus an SSRI (specifically sertraline) as first-line treatment for adolescents with social anxiety and panic disorder, demonstrating superior efficacy compared to either treatment alone 1
• CBT combined with sertraline is the recommended initial treatment for adolescents aged 6-18 years with social anxiety and panic disorder, showing moderate strength of evidence for improved anxiety symptoms, global function, treatment response, and disorder remission compared to monotherapy 1
• The Child-Adolescent Anxiety Multimodal Study (CAMS) demonstrated that combination treatment was significantly superior to either CBT alone or medication alone in initial treatment response, which strongly predicted long-term outcomes 1

Specific Medication Recommendations

• Sertraline is the first-choice SSRI for adolescents with social anxiety and panic disorder, with FDA approval and extensive evidence base 1
• Alternative SSRI options, such as fluoxetine, escitalopram, and citalopram, can be considered if sertraline is not tolerated, as they also have evidence for anxiety disorders 1

Cognitive-Behavioral Therapy Specifications

• Exposure-based interventions targeting social and performance situations that trigger panic attacks are recommended 1
• Parent involvement is beneficial, particularly if parents themselves have anxiety 1, 2

Critical Monitoring Requirements

• Monitor closely for suicidal ideation and behavior, especially in the first weeks after starting or increasing SSRI dose, as adolescents have increased risk 1
• Assess for behavioral activation/agitation, which can occur early in SSRI treatment 1

School Accommodation Considerations

• Coordinate with school to implement accommodations for panic attacks (safe space, ability to leave class briefly) 2
• Consider 504 plan or IEP modifications to address functional impairments in schoolwork and social situations 2

Common Pitfalls to Avoid

• Do not use benzodiazepines as first-line treatment in adolescents despite their rapid anxiolytic effect, due to risks of dependence, cognitive impairment, and lack of evidence for long-term efficacy 1
• Do not delay treatment waiting for "the perfect intervention"—early effective treatment predicts better long-term outcomes 1
• Do not treat in isolation—coordinate care between mental health provider, primary care, and school 2
• Do not ignore parental anxiety, which can inadvertently reinforce avoidance behaviors; consider parental treatment if indicated 1, 2